<DOC>
	<DOCNO>NCT01332201</DOCNO>
	<brief_summary>Comparison tacrolimus blood level adult receive transplant take either Prograf Advagraf anti-rejection therapy immediately follow surgery . This follow check safety effectiveness one year .</brief_summary>
	<brief_title>Study Compare Pharmacokinetics Tacrolimus Adult Transplant Recipients Treated With Advagraf® Prograf®</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>must receive first oral dose tacrolimus one day ( lung , pancreas Simultaneous Pancreas Kidney ( SPK ) recipient ) three day ( heart recipient ) transplantation ( skin closure ) negative pregnancy test prior enrolment ( female ) agree practice effective birth control study treat since transplantation Antithymocyte globulin/ Mycophenolate Mofetil/steroids ( ATG/MMF/steroids ) , gastric motility resume renal function adequate ( &lt; 230 µmol/l ( &lt; 2.6 ml/dl ) ) Day 1 receive multiorgan transplant ( exception SPK ) previously receive organ transplant ( include retransplantation ) pulmonary vascular resistance ≥4 Wood unit despite medication require emergency ventricular assist device within one week prior transplantation significant renal impairment significant liver disease malignancy history malignancy within last 5 year significant , uncontrolled concomitant infection and/or severe diarrhoea , vomit , active upper gastrointestinal disorder may affect absorption tacrolimus , active peptic ulcer require systemic immunosuppressive medication indication transplantation diagnosis cystic fibrosis pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Advagraf</keyword>
	<keyword>Heart</keyword>
	<keyword>Lung</keyword>
	<keyword>Pancreas</keyword>
	<keyword>Transplant</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>